NDC 69880-120

Mycapssa

Octreotide

Mycapssa is a Oral Capsule, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Amryt Pharmaceuticals Designated Activity Company. The primary component is Octreotide.

• Product ID: 69880-120_55f04a73-a366-4c65-9ed5-c3051668fa19
• NDC: 69880-120
• Product Type: Human Prescription Drug
• Proprietary Name: Mycapssa
• Generic Name: Octreotide
• Dosage Form: Capsule, Delayed Release
• Route of Administration: ORAL
• Marketing Start Date: 2020-07-06
• Marketing Category: NDA / NDA
• Application Number: NDA208232
• Labeler Name: Amryt Pharmaceuticals Designated Activity Company
• Substance Name: OCTREOTIDE
• Active Ingredient Strength: 20 mg/1
• Pharm Classes: Somatostatin Analog [EPC], Somatostatin Receptor Agonists [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 69880-120-28

4 BLISTER PACK in 1 DOSE PACK (69880-120-28) > 7 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK

• Marketing Start Date: 2020-07-06
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details